Skip to Content

Stock movement: Invacare, ResMed

Stock movement: Invacare, ResMed

InvacareCFO Robert Gudbranson bought 4,200 company shares at an average price of $12.01 per share in a transaction on Feb. 29 worth $50,442. He now owns 101,821 shares worth about $1.2 million. Additionally, Invacare Vice President Anthony Laplaca bought 1,000 company shares at an average price of $12.38 per share in a transaction on Feb. 29 worth about $12,400. Invacare announced in February that it is preparing to submit a final report to lift its consent decree with the Food and Drug Administration…ResMed CFO Brett Sandercock sold 30,000 company shares for an average of $57.61 per share in a transaction on Feb. 26 worth about $1.7 million. He now has 132,136 shares worth about $7.6 million. Janus Capital Management increased its number of shares in ResMed by 345,234 in the third quarter for a total of 494,328 shares. It now has a $25.2 million stake in the company. ResMed has made headlines recently by buying Brightree and Inova Technologies.

Comments

To comment on this post, please log in to your account or set up an account now.